Trials / Completed
CompletedNCT05710874
A Prospective, Randomized, Clinical Study on the Effects of CPP-ACP-paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding.
A Prospective, Randomized, Clinical Study on the Effects of Casein Phosphopeptide Amorphous Calcium Phosphate Paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 12 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The goal of this randomized clinical trial is to compare the influence of casein phosphopeptide amorphous calcium phosphate (CPP-ACP), CPP-ACP in combination with fluoride (CPP-ACPF), high fluoride concentration, and conventional fluoride toothpaste on the color and size of white spot lesions (WSLs) in orthodontic patients following bracket removal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CPP-ACP paste | Daily application of CPP-ACP (Casein phosphopeptide amorphous calcium phosphate) paste (Tooth Mousse®) in addition to twice daily use of conventional toothpaste. |
| OTHER | CPP-ACPF paste | Daily application of CPP-ACPF (Casein phosphopeptide amorphous calcium phosphate in combination with fluoridepaste) (MI Paste Plus®) in addition to twice daily use of conventional toothpaste. |
| OTHER | 1.25% fluoride gel | Weekly application of 1.25% fluoride gel (Elmex Medical Gel®) in addition to twice daily use of conventional toothpaste. |
| OTHER | Conventional | Twice daily use of conventional toothpaste. |
Timeline
- Start date
- 2016-09-23
- Primary completion
- 2023-03-29
- Completion
- 2023-03-29
- First posted
- 2023-02-02
- Last updated
- 2023-08-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05710874. Inclusion in this directory is not an endorsement.